Metabolic treatment: A potential breakthrough in diabetic heart disease
May 1, 2025
SGLT2i-drug induced hyperketonemia improved cardiac function for Type 2 diabetic patients with heart failure Heart disease is the leading cause of death for people with Type 2 diabetes and people with diabetes are more than twice as likely to experience a heart attack or stroke, according to the American Diabetes Association. While most cardiologists focus on […]